MullardA: FDA approves 100th monoclonal antibody product. Nat Rev Drug Discov. 2021; 5:021-00079.
2.
PatelA, BahMA, WeinerDB: In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies. BioDrugs. 2020; 34:273–293. doi: 210.1007/s40259-40020-00412-40253.
3.
SteplewskiZ, ThurinM, Kieber-EmmonsT: Antibodies: At The Nexus of Antigens and Cancer Vaccines. J Infect Dis. 2015; 212Suppl 1:S59–66. doi: 10.1093/infdis/jiu1638.
4.
SearsHF, AtkinsonB, MattisJ, ErnstC, HerlynD, SteplewskiZ, HäyryP, KoprowskiH: Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours. Lancet. 1982; 1:762–765. doi: 710.1016/s0140-6736(1082)91811-91816.
5.
HerlynD, WettendorffM, SchmollE, IliopoulosD, SchedelI, DreikhausenU, RaabR, RossAH, JakscheH, ScribaM, et al.: Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc Natl Acad Sci U S A. 1987; 84:8055–8059. doi: 8010.1073/pnas.8084.8022.8055.
6.
KoprowskiH, SteplewskiZ, HerlynD, HerlynM: Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A. 1978; 75:3405–3409. doi: 3410.1073/pnas.3475.3407.3405.
7.
KoprowskiH, HerlynD, LubeckM, DeFreitasE, SearsHF: Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?. Proc Natl Acad Sci U S A. 1984; 81:216–219. doi: 210.1073/pnas.1081.1071.1216.
8.
BechtelB, WandAJ, WroblewskiK, KoprowskiH, ThurinJ: Conformational analysis of the tumor-associated carbohydrate antigen 19-9 and its Lea blood group antigen component as related to the specificity of monoclonal antibody CO19-9. J Biol Chem. 1990; 265:2028–2037.
9.
Blaszczyk-ThurinM, MuraliR, WesterinkMA, SteplewskiZ, CoMS, Kieber-EmmonsT: Molecular recognition of the Lewis Y antigen by monoclonal antibodies. Protein Eng. 1996; 9:447–459. doi: 410.1093/protein/1099.1095.1447.
10.
PichlaSL, MuraliR, BurnettRM: The crystal structure of a Fab fragment to the melanoma-associated GD2 ganglioside. J Struct Biol. 1997; 119:6–16. doi: 10.1006/jsbi.1997.3857.
11.
SunJ, ThurinJ, CooperHS, WangP, MackiewiczM, SteplewskiZ, Blaszczyk-ThurinM: Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci U S A. 1995; 92:5724–5728. doi: 5710.1073/pnas.5792.5712.5724.
12.
HerlynM, SteplewskiZ, HerlynD, KoprowskiH: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A. 1979; 76:1438–1442. doi: 1410.1073/pnas.1476.1433.1438.
13.
IliopoulosD, ErnstC, SteplewskiZ, JambrosicJA, RodeckU, HerlynM, ClarkWHJr., KoprowskiH, HerlynD: Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer Inst. 1989; 81:440–444. doi: 410.1093/jnci/1081.1096.1440.